The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
The global Idhifa market was valued at US$ 78 million in 2023 and is anticipated to reach US$ 125.9 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.
This report aims to provide a comprehensive presentation of the global market for Idhifa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idhifa.
Report Scope
The Idhifa market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Idhifa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Idhifa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol Myers Squibb
Segment by Type
50mg
100mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Idhifa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Idhifa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
The global Idhifa market was valued at US$ 78 million in 2023 and is anticipated to reach US$ 125.9 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.
This report aims to provide a comprehensive presentation of the global market for Idhifa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idhifa.
Report Scope
The Idhifa market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Idhifa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Idhifa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol Myers Squibb
Segment by Type
50mg
100mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Idhifa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Idhifa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Idhifa Market Overview
1.1 Product Overview and Scope of Idhifa
1.2 Idhifa Segment by Type
1.2.1 Global Idhifa Market Value Comparison by Type (2024-2030)
1.2.2 50mg
1.2.3 100mg
1.3 Idhifa Segment by Application
1.3.1 Global Idhifa Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Idhifa Market Size Estimates and Forecasts
1.4.1 Global Idhifa Revenue 2019-2030
1.4.2 Global Idhifa Sales 2019-2030
1.4.3 Global Idhifa Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Idhifa Market Competition by Manufacturers
2.1 Global Idhifa Sales Market Share by Manufacturers (2019-2024)
2.2 Global Idhifa Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Idhifa Average Price by Manufacturers (2019-2024)
2.4 Global Idhifa Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Idhifa, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Idhifa, Product Type & Application
2.7 Idhifa Market Competitive Situation and Trends
2.7.1 Idhifa Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Idhifa Players Market Share by Revenue
2.7.3 Global Idhifa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Idhifa Retrospective Market Scenario by Region
3.1 Global Idhifa Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Idhifa Global Idhifa Sales by Region: 2019-2030
3.2.1 Global Idhifa Sales by Region: 2019-2024
3.2.2 Global Idhifa Sales by Region: 2025-2030
3.3 Global Idhifa Global Idhifa Revenue by Region: 2019-2030
3.3.1 Global Idhifa Revenue by Region: 2019-2024
3.3.2 Global Idhifa Revenue by Region: 2025-2030
3.4 North America Idhifa Market Facts & Figures by Country
3.4.1 North America Idhifa Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Idhifa Sales by Country (2019-2030)
3.4.3 North America Idhifa Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Idhifa Market Facts & Figures by Country
3.5.1 Europe Idhifa Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Idhifa Sales by Country (2019-2030)
3.5.3 Europe Idhifa Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Idhifa Market Facts & Figures by Country
3.6.1 Asia Pacific Idhifa Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Idhifa Sales by Country (2019-2030)
3.6.3 Asia Pacific Idhifa Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Idhifa Market Facts & Figures by Country
3.7.1 Latin America Idhifa Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Idhifa Sales by Country (2019-2030)
3.7.3 Latin America Idhifa Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Idhifa Market Facts & Figures by Country
3.8.1 Middle East and Africa Idhifa Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Idhifa Sales by Country (2019-2030)
3.8.3 Middle East and Africa Idhifa Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Idhifa Sales by Type (2019-2030)
4.1.1 Global Idhifa Sales by Type (2019-2024)
4.1.2 Global Idhifa Sales by Type (2025-2030)
4.1.3 Global Idhifa Sales Market Share by Type (2019-2030)
4.2 Global Idhifa Revenue by Type (2019-2030)
4.2.1 Global Idhifa Revenue by Type (2019-2024)
4.2.2 Global Idhifa Revenue by Type (2025-2030)
4.2.3 Global Idhifa Revenue Market Share by Type (2019-2030)
4.3 Global Idhifa Price by Type (2019-2030)
5 Segment by Application
5.1 Global Idhifa Sales by Application (2019-2030)
5.1.1 Global Idhifa Sales by Application (2019-2024)
5.1.2 Global Idhifa Sales by Application (2025-2030)
5.1.3 Global Idhifa Sales Market Share by Application (2019-2030)
5.2 Global Idhifa Revenue by Application (2019-2030)
5.2.1 Global Idhifa Revenue by Application (2019-2024)
5.2.2 Global Idhifa Revenue by Application (2025-2030)
5.2.3 Global Idhifa Revenue Market Share by Application (2019-2030)
5.3 Global Idhifa Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Idhifa Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb Idhifa Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Idhifa Industry Chain Analysis
7.2 Idhifa Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Idhifa Production Mode & Process
7.4 Idhifa Sales and Marketing
7.4.1 Idhifa Sales Channels
7.4.2 Idhifa Distributors
7.5 Idhifa Customers
8 Idhifa Market Dynamics
8.1 Idhifa Industry Trends
8.2 Idhifa Market Drivers
8.3 Idhifa Market Challenges
8.4 Idhifa Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
